Abeona therapeutics receives european medicines agency prime designation for abo-102 gene therapy in mps iiia

Abeona therapeutics receives european medicines agency prime designation for abo-102 gene therapy in mps iiia.abeona therapeutics - prime designation for abo-102 gene therapy in mps iiia based on nonclinical data and clinical data from transpher a study.

ABEO Ratings Summary

ABEO Quant Ranking